Warnock will work to cap insulin costs at $35 per month.

That’s why he’s leading the effort to cap the cost of insulin, a medical necessity for the more than one million Georgians with Diabetes, at $35 a month.

Warnock commits to pursuing a $35 monthly cap on insulin costs.

Health Care: The Right to Access Affordable, Quality Care - Warnock for Georgia
campaign · campaign_site · model gpt-5.5

Congress.gov lists Sen. Raphael G. Warnock as sponsor, introduced February 17, 2022. The CRS summary says the bill limited insulin cost-sharing in private insurance and Medicare drug coverage, including a $35 monthly cap structure.

Warnock introduced concrete legislation directly matching the $35-per-month insulin cost-sharing promise, but the bill itself remained at the introduced stage.

partial same_term A for effort

S.3700 - Affordable Insulin Now Act, 117th Congress
secondary · model gpt-5.5 · confidence 98%

The Senate vote was on a motion to waive budget rules for Amendment No. 5194, Insulin. It required three-fifths, was rejected 57-43, and Warnock voted Yea.

Warnock voted to advance the insulin provision during Inflation Reduction Act consideration, but the procedural motion failed, showing a blocked attempt rather than full enactment.

partial same_term A for effort

U.S. Senate Roll Call Vote 314, 117th Congress, 2nd Session
secondary · model gpt-5.5 · confidence 95%

The enacted law created Medicare insulin cost-sharing rules: Part D covered insulin had a $35 applicable copayment for plan years 2023-2025, and certain Part B pump insulin coinsurance could not exceed $35 for a month's supply.

A $35 insulin cap became law for Medicare Part D and certain Part B insulin. This delivered a major part of the promise, but not a universal cap for private insurance or uninsured users.

partial same_term

Public Law 117-169 - Inflation Reduction Act of 2022, insulin provisions
secondary · model gpt-5.5 · confidence 98%

CMS states that Medicare beneficiaries taking covered insulin have access to each insulin for no more than $35 for a month's supply, with rules beginning January 1, 2023 for Medicare drug plans and July 1, 2023 for traditional pump insulin.

The $35 cap was implemented for Medicare insulin users, confirming real-world delivery for that covered population while leaving non-Medicare users outside the federal statutory cap.

partial same_term

CMS Fact Sheet: The Inflation Reduction Act Lowers Health Care Costs for Millions of Americans
secondary · model gpt-5.5 · confidence 97%

GovInfo lists S.4189 as introduced March 25, 2026, with Raphael G. Warnock as a cosponsor. The bill's title is to reduce insulin prices and protect patients, and its last action was referral to the Senate HELP Committee.

As of April 27, 2026, Warnock was still advancing legislation to extend insulin affordability protections beyond Medicare, which supports continued effort but also shows the broader cap was not fully enacted federally.

partial same_term A for effort

S.4189 - Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026
secondary · model gpt-5.5 · confidence 93%